PARP10 and cancer: More recently, molecular dynamics simulations and virtual modeling tests have shed new light on the characterization of new PARP10 molecules, considering a pharmacokinetic criterion, the molecule pharmacophore-based virtual screening was performed on ZINC and NCI libraries has identified that the compound ZINC20906412 offers high therapeutic potential in cancer, although these studies need to be further developed by performing extensive testing in cell models [102].